Neoadjuvant vs. adjuvant chemotherapy for cholangiocarcinoma: A propensity score matched analysis

被引：0
|
作者：
Yadav, S. [1 ]
Xie, H. [1 ]
Riaz, I. B. [1 ]
Sharma, P. [2 ]
Mahipal, A. [1 ]
McWilliams, R. [1 ]
机构：
[1] Mayo Clin, Dept Oncol, Rochester, MN USA
[2] Yale New Haven Hlth Syst, Bridgeport Hosp, Dept Internal Med, Bridgeport, CT USA
来源：
ANNALS OF ONCOLOGY | 2018年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
763P
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Chemoradiation Therapy for Unresected Extrahepatic Cholangiocarcinoma: A Propensity Score-Matched Analysis
    Torgeson, Anna
    Lloyd, Shane
    Boothe, Dustin
    Cannon, George
    Garrido-Laguna, Ignacio
    Whisenant, Jonathan
    Lewis, Mark
    Kim, Robin
    Scaife, Courtney
    Tao, Randa
    ANNALS OF SURGICAL ONCOLOGY, 2017, 24 (13) : 4001 - 4008
  • [42] The effect of adjuvant chemotherapy in patients with intrahepatic cholangiocarcinoma: a matched pair analysis
    Schweitzer, Nora
    Weber, Tim
    Kirstein, Martha M.
    Fischer, Mareike
    Kratzel, Anna-Maria
    Reineke-Plaass, Tanja
    Lehner, Frank
    Manns, Michael P.
    Vogel, Arndt
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2017, 143 (07) : 1347 - 1355
  • [43] Efficacy and Safety of Neoadjuvant Chemotherapy Combined with Adjuvant Chemotherapy for Locally Advanced Colon Cancer: A Propensity Score-Matching Analysis
    Zeng, Wei
    Liu, Yi
    Wang, Chuandong
    Yang, Changshun
    Lin, Shengtao
    Li, Weihua
    MEDICINA-LITHUANIA, 2022, 58 (11):
  • [44] Chemoradiation Therapy for Unresected Extrahepatic Cholangiocarcinoma: A Propensity Score-Matched Analysis
    Anna Torgeson
    Shane Lloyd
    Dustin Boothe
    George Cannon
    Ignacio Garrido-Laguna
    Jonathan Whisenant
    Mark Lewis
    Robin Kim
    Courtney Scaife
    Randa Tao
    Annals of Surgical Oncology, 2017, 24 : 4001 - 4008
  • [45] Neoadjuvant therapy with immune checkpoint inhibitors in combination with chemotherapy vs. chemotherapy alone in HER2(-) locally advanced gastric cancer: A propensity score-matched cohort study
    Xu, Gehan
    Liu, Tianjiao
    Shen, Jingyi
    Guan, Quanlin
    CHINESE MEDICAL JOURNAL, 2025, 138 (04) : 459 - 471
  • [46] Neoadjuvant therapy with immune checkpoint inhibitors in combination with chemotherapy vs. chemotherapy alone in HER2(-) locally advanced gastric cancer: A propensity score-matched cohort study
    Xu Gehan
    Liu Tianjiao
    Shen Jingyi
    Guan Quanlin
    中华医学杂志英文版, 2025, 138 (04)
  • [47] A population-based propensity score matching analysis of neoadjuvant compared to adjuvant chemotherapy in luminal breast cancer
    Zheng, Chenhui
    Zheng, Danni
    Zhang, Yuzhu
    Lin, Renzhi
    Zheng, Zhibao
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [48] THE ROLE OF NEOADJUVANT VERSUS ADJUVANT THERAPY FOR DUODENAL ADENOCARCINOMA: A NATIONAL CANCER DATABASE (NCDB) PROPENSITY SCORE MATCHED ANALYSIS
    Linden, Kimberly M.
    Melillo, Atlee M.
    John, Gaughan
    Obinero, Chioma G.
    Atabek, Umur
    Spitz, Francis
    Hong, Young
    GASTROENTEROLOGY, 2019, 156 (06) : S1408 - S1408
  • [49] Adjuvant chemotherapy versus chemoradiation in high-risk pancreatic adenocarcinoma: A propensity score-matched analysis
    Raoof, Mustafa
    Blakely, Andrew M.
    Melstrom, Laleh G.
    Lee, Byrne
    Warner, Susanne G.
    Chung, Vincent
    Singh, Gagandeep
    Chen, Yi-Jen
    Fong, Yuman
    CANCER MEDICINE, 2019, 8 (13): : 5881 - 5890
  • [50] Adjuvant transarterial chemotherapy for margin-positive resection of hepatocellular carcinoma-a propensity score matched analysis
    Fok, Alvina Jada
    She, Wong Hoi
    Ma, Ka Wing
    Tsang, Simon H. Y.
    Dai, Wing Chiu
    Chan, Albert C. Y.
    Lo, Chung Mau
    Cheung, Tan To
    LANGENBECKS ARCHIVES OF SURGERY, 2022, 407 (01) : 245 - 257
12345